Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EP2163 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Body temperature, Coma, Death, Pyrexia
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Medical History/Concurrent Conditions: Dementia; Parkinson''s disease
Diagnostic Lab Data: Test Date: 20210306; Test Name: body temperature; Result Unstructured Data: Test Result:41 Centigrade
CDC 'Split Type': DEPFIZER INC2021282962
Write-up: Exitus letalis/Death; Fever 41 Centigrade; comatose; This is a spontaneous report from a non-contactable physician from the Agency Regulatory Authority-WEB DE-PEI-PEI2021003289. An 86-year-old male patient received the second dose of BNT162B2 (COMIRNATY, Batch/Lot Number: EP2163), via an unspecified route of administration at the age of 86 years old on 05Mar2021 at single dose for covid-19 immunisation. Medical history included Parkinson''s disease from an unknown date and unknown if ongoing, dementia from an unknown date and unknown if ongoing. The patient''s concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration at the age of 86 years old on 12Feb2021 at single dose for covid-19 immunisation and had been tolerated. The patient experienced exitus letalis (as reported) /death on 10Mar2021, fever 41 centigrade on 06Mar2021, comatose on 06Mar2021. 1 day after vaccination on 06Mar2021 the patient developed hyperpyrexia and comatose and then death, lasting for unknown. The patient died on 10Mar2021. An autopsy was performed and results were not provided. The outcome of the events was fatal. No follow-up attempts are possible. No further information is expected.; Sender''s Comments: The reported event ''hyperpyrexia'' was confirmed with temperature value below 41.5?C (or 106.7?F, choose the appropriate value), a value which, from a medical point of view is not consistent with ''hyperpyrexia''. The Company therefore coded this event as ''pyrexia''; Reported Cause(s) of Death: Exitus letalis/Death; Fever 41 ? C; Comatose
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166